Attached files
file | filename |
---|---|
EX-31.2 - EXHIBIT 31.2 - CHEMBIO DIAGNOSTICS, INC. | brhc10016471_31-2.htm |
EX-31.1 - EXHIBIT 31.1 - CHEMBIO DIAGNOSTICS, INC. | brhc10016471_31-1.htm |
10-Q - 10-Q - CHEMBIO DIAGNOSTICS, INC. | brhc10016471_10q.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the
Quarterly Report on Form 10-Q of Chembio Diagnostics, Inc. for the quarterly period ended September 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned certifies, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge on the date hereof:
1. the Report fully
complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. the information
contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Chembio Diagnostics, Inc. for the period presented therein.
Date: November 5, 2020
|
/s/ Richard L. Eberly
|
Richard L. Eberly
|
|
Chief Executive Officer and President
|
|
(Principal Executive Officer)
|
Date: November 5, 2020
|
/s/ Neil A. Goldman
|
Neil A. Goldman
|
|
Chief Financial Officer and Executive Vice President
|
|
(Principal Financial Officer)
|
The foregoing
certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Report or as a separate disclosure document.